Dr. Lal Path Labs Ltd. (LALPATHLAB) Share Analysis
NSE · Healthcare · Hospital & Healthcare Services
Dr. Lal Path Labs Ltd. (NSE: LALPATHLAB) is an Indian listed company in the Hospital & Healthcare Services sector and a constituent of NIFTY 500, NIFTY MidSmallcap 400, NIFTY Smallcap 100. As of 14 Nov 2026, the share price was ₹1,993.00, P/E 55.2, ROE 22.3%.
Get the AI verdict on LALPATHLAB: BUY, BUY ON DIPS, WAIT or EXIT
Sign in for the full analysis — AI fundamental and technical analysis, recent news, and one verdict with an entry zone, two targets and a stop-loss, for a 3-month, 1-year, 3-year or 5-year horizon. A free plan is available.
LALPATHLAB chart with trendlines
Is LALPATHLAB a buy right now?
Sign in free for the AI verdict with entry zone, targets and stop-loss.
About Dr. Lal Path Labs Ltd.
Stored fundamentals as of 14 Nov 2026 — not a live quote. Signed-in analysis uses same-day data.
LALPATHLAB key facts
| Price and valuation | |
|---|---|
| Share price | ₹1,993.00 |
| Market cap | ₹33,452 Cr |
| P/E ratio | 55.2 |
| P/B ratio | 12.15 |
| EPS | ₹34.90 |
| Book value per share | ₹164.00 |
| Dividend yield | 0.7% |
| 52-week range | |
| 52-week high | ₹2,079.00 |
| 52-week low | ₹1,272.60 |
| Face value | ₹10.00 |
| Shareholding pattern | |
| Promoters | 52.93% |
| FIIs | 18.73% |
| DIIs | 21.57% |
| Public | 6.35% |
Index membership: NIFTY 500, NIFTY MidSmallcap 400, NIFTY Smallcap 100, NIFTY Smallcap 250, NIFTY Smallcap 50.
Learn to read these numbers
- Metrics glossary — what P/E, ROE, ROCE and debt-to-equity mean.
- Investment Blogs — free lessons on fundamental and technical analysis.
- AI stock picks and Discover stocks by sector and index.
- How Stock-Analyze works — what the AI analysis and verdict cover.